Ruth Duncan
13Patents
8h-index
27Co-inventors
68Inventor score
Filing activity: Nov 17, 1989 → Mar 18, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5037883A | Synthetic polymeric drugs | Emerging Cross-Sectional Technologies | 62 | Expired |
| US5622718A | Alginate-bioactive agent conjugates | Human Necessities | 38 | Expired |
| US5985916A | Polymer-platinum compounds | Human Necessities | 22 | Expired |
| US6372205B1 | Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs | Performing Operations; Transporting | 15 | Expired |
| US5738864A | Drug delivery agents incorporating mitomycin | Human Necessities | 14 | Expired |
| US7220414B2 | Degradable polyacetal polymers | Chemistry; Metallurgy | 14 | Expired |
| US5965118A | Polymer-platinum compounds | Human Necessities | 13 | Expired |
| US6585956B2 | Dendritic-platinate drug delivery system | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6338843B1 | Biologically active materials | Human Necessities | 3 | Expired |
| US6790437B2 | Method of treating cancerous tumors with a dendritic-platinate drug delivery system | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6818630B1 | Biologically active materials | Human Necessities | 0 | Expired |
| US7005124B2 | Dendritic-antineoplastic drug delivery system | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8058344B2 | Glycodendrimers having biological activity | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.